Engineering and preclinical evaluation of attenuated nontyphoidal salmonella strains serving as live oral vaccines and as reagent strains

Infection and Immunity

Volumn 79, Issue 10, 2011, Pages 4175-4185

  Tennant, Sharon M ^a   Wang, Jin Yuan ^a   Galen, James E ^a   Simon, Raphael ^a   Pasetti, Marcela F ^a   Gat, Orit G ^a   Levine, Myron M ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; GUANINE; IMMUNOGLOBULIN G; LIVE VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BIOSYNTHESIS; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; IMMUNIZATION; LETHAL DOSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA; SALMONELLA DUBLIN; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; VACCINE PRODUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GENETIC ENGINEERING; GUANINE; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; VACCINES, ATTENUATED;

EID: 80855136559     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05278-11     Document Type: Article

References (64)

1. Adak, G. K., S. M. Long, and S. J. O'Brien. 2002. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 51:832-841.
2. Allen-Vercoe, E., A. R. Sayers, and M. J. Woodward. 1999. Virulence of Salmonella enterica serotype Enteritidis aflagellate and afimbriate mutants in a day-old chick model. Epidemiol. Infect. 122:395-402.
3. Angelakopoulos, H., and E. L. Hohmann. 2000. Pilot study of phoP/phoQdeleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun. 68:2135-2141.
4. Armah, G. E., et al. 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in subSaharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376:606-614.
5. Auvray, F., J. Thomas, G. M. Fraser, and C. Hughes. 2001. Flagellin polymerisation control by a cytosolic export chaperone. J. Mol. Biol. 308:221-229.
6. Babu, U., et al. 2003. Effects of live attenuated and killed Salmonella vaccine on T-lymphocyte mediated immunity in laying hens. Vet. Immunol. Immunopathol. 91:39-44.
7. Berkley, J. A., et al. 2005. Bacteremia among children admitted to a rural hospital in Kenya. N. Engl. J. Med. 352:39-47.
8. Brent, A. J., et al. 2006. Salmonella bacteremia in Kenyan children. Pediatr. Infect. Dis. J. 25:230-236.
9. Chalker, A. F., et al. 2001. Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J. Bacteriol. 183:1259-1268.
10. Cryz, S. J., Jr., et al. 1993. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Infect. Immun. 61:1149-1151.
11. Cummings, L. A., S. L. Barrett, W. D. Wilkerson, I. Fellnerova, and B. T. Cookson. 2005. FliC-specific CD4 T cell responses are restricted by bacterial regulation of antigen expression. J. Immunol. 174:7929-7938.
12. Cummings, L. A., W. D. Wilkerson, T. Bergsbaken, and B. T. Cookson. 2006. In vivo, fliC expression by Salmonella enterica serovar Typhimurium is heterogeneous, regulated by ClpX, and anatomically restricted. Mol. Microbiol. 61:795-809.
13. Cunningham, A. F., et al. 2004. Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1. Eur. J. Immunol. 34:2986-2995.
14. Curtiss, R., III, and J. O. Hassan. 1996. Nonrecombinant and recombinant avirulent Salmonella vaccines for poultry. Vet. Immunol. Immunopathol. 54:365-372.
15. Darveau, R. P., and R. E. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831-838.
16. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
17. Enwere, G., et al. 2006. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr. Infect. Dis. J. 25:700-705.
18. Galan, J., and R. Curtiss III. 1989. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb. Pathog. 6:433-443.
19. Gillen, K. L., and K. T. Hughes. 1991. Molecular characterization of flgM, a gene encoding a negative regulator of flagellin synthesis in Salmonella typhimurium. J. Bacteriol. 173:6453-6459.
20. Gondwe, E. N., et al. 2010. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc. Natl. Acad. Sci. U. S. A. 107:3070-3075.
21. Gordon, M. A. 2008. Salmonella infections in immunocompromised adults. J. Infect. 56:413-422.
22. Graham, S. M. 2002. Salmonellosis in children in developing and developed countries and populations. Curr. Opin. Infect. Dis. 15:507-512.
23. Graham, S. M., A. L. Walsh, E. M. Molyneux, A. J. Phiri, and M. E. Molyneux. 2000. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans. R. Soc. Trop. Med. Hyg. 94:310-314.
24. Hindle, Z., et al. 2002. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect. Immun. 70:3457-3467.
25. Holt, P. S., R. K. Gast, and S. Kelly-Aehle. 2003. Use of a live attenuated Salmonella typhimurium vaccine to protect hens against Salmonella enteritidis infection while undergoing molt. Avian Dis. 47:656-661.
26. Homma, M., H. Fujita, S. Yamaguchi, and T. Iino. 1984. Excretion of unassembled flagellin by Salmonella typhimurium mutants deficient in hookassociated proteins. J. Bacteriol. 159:1056-1059.
27. Homma, M., and T. Iino. 1985. Locations of hook-associated proteins in flagellar structures of Salmonella typhimurium. J. Bacteriol. 162:183-189.
28. Homma, M., K. Kutsukake, T. Iino, and S. Yamaguchi. 1984. Hook-associated proteins essential for flagellar filament formation in Salmonella typhimurium. J. Bacteriol. 157:100-108.
29. Hormaeche, C. E., H. S. Joysey, L. Desilva, M. Izhar, and B. A. Stocker. 1990. Immunity induced by live attenuated Salmonella vaccines. Res. Microbiol. 141:757-764.
30. Hormaeche, C. E., H. S. Joysey, L. Desilva, M. Izhar, and B. A. Stocker. 1991. Immunity conferred by Aro-Salmonella live vaccines. Microb. Pathog. 10:149-158.
31. Ikeda, T., S. Asakura, and R. Kamiya. 1985. "Cap" on the tip of Salmonella flagella. J. Mol. Biol. 184:735-737.
32. Ikumapayi, U. N., et al. 2007. Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2-29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri. J. Med. Microbiol. 56:1479-1484.
33. John, T. J., and P. Jayabal. 1972. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am. J. Epidemiol. 96:263-269.
34. John, T. J., and V. M. Vashishtha. 2009. Eradication of vaccine polioviruses: why, when & how? Indian J. Med. Res. 130:491-494.
35. Kariuki, S., et al. 2006. Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol. 6:101.
36. Kennedy, M., et al. 2004. Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clin. Infect. Dis. 38(Suppl. 3):S142-S148.
37. Kodama, C., and H. Matsui. 2004. Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains. Infect. Immun. 72:2449-2451.
38. Kotloff, K. L., et al. 2004. Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a Phase 1 trial of CVD 1204 and CVD 1208. J. Infect. Dis. 190:1745-1754.
39. Lepage, P., et al. 1987. Community-acquired bacteraemia in African children. Lancet i:1458-1461.
40. Levine, M. M., et al. 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17(Suppl. 2):S22-S27.
41. Levy, H., et al. 2008. PCR method to identify Salmonella enterica serovars Typhi, Paratyphi A, and Paratyphi B among Salmonella isolates from the blood of patients with clinical enteric fever. J. Clin. Microbiol. 46:1861-1866.
42. Madhi, S. A., et al. 2010. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362:289-298.
43. Mandomando, I., et al. 2009. Invasive non-typhoidal Salmonella in Mozambican children. Trop. Med. Int. Health 14:1467-1474.
44. Matsui, H., et al. 2003. Oral immunization with ATP-dependent proteasedeficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar Typhimurium. Infect. Immun. 71:30-39.
45. Na, H. S., et al. 2006. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis. Vaccine 24:2027-2034.
46. O'Dempsey, T. J., et al. 1994. Importance of enteric bacteria as a cause of pneumonia, meningitis and septicemia among children in a rural community in The Gambia, West Africa. Pediatr. Infect. Dis. J. 13:122-128.
47. Olanratmanee, T., M. M. Levine, G. Losonsky, U. Thisyakorn, and S. J. Cryz, Jr. 1992. Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year old Thai children. J. Infect. Dis. 166:451-452.
48. Patriarca, P. A., P. F. Wright, and T. J. John. 1991. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries. Rev. Infect. Dis. 13:926-929.
49. Robertson, J. M., et al. 2003. Lack of flagella disadvantages Salmonella enterica serovar Enteritidis during the early stages of infection in the rat. J. Med. Microbiol. 52:91-99.
50. Rondini, S., et al. 2011. Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi. Clin. Vaccine Immunol. 18:460-468.
51. Sigauque, B., et al. 2009. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr. Infect. Dis. J. 28:108-113.
52. Simon, R., and C. E. Samuel. 2007. Activation of NF-kappaB-dependent gene expression by Salmonella flagellins FliC and FljB. Biochem. Biophys. Res. Commun. 355:280-285.
53. Simonsen, L., A. Kane, J. Lloyd, M. Zaffran, and M. Kane. 1999. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull. World Health Organ. 77:789-800.
54. Tennant, S. M., et al. 2010. Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali. PLoS Negl. Trop. Dis. 4:e621.
55. Tomoyasu, T., et al. 2002. The ClpXP ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar Typhimurium. J. Bacteriol.184:645-653.
56. Tomoyasu, T., A. Takaya, E. Isogai, and T. Yamamoto. 2003. Turnover of FlhD and FlhC, master regulator proteins for Salmonella flagellum biogenesis, by the ATP-dependent ClpXP protease. Mol. Microbiol. 48:443-452.
57. Varma, J. K., et al. 2005. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J. Infect. Dis. 191:554-561.
58. Voetsch, A. C., et al. 2004. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin. Infect. Dis. 38(Suppl. 3):S127-S134.
59. Vugia, D. J., et al. 2004. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin. Infect. Dis. 38(Suppl. 3):S149-S156.
60. Walsh, A. L., A. J. Phiri, S. M. Graham, E. M. Molyneux, and M. E. Molyneux. 2000. Bacteremia in febrile Malawian children: clinical and microbiologic features. Pediatr. Infect. Dis. J. 19:312-318.
61. Wang, J. Y., et al. 2001. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated δguaBA Salmonella enterica serovar Typhi strain CVD 915. Infect. Immun. 69:4734-4741.
62. Yokoseki, T., K. Kutsukake, K. Ohnishi, and T. Iino. 1995. Functional analysis of the flagellar genes in the fliD operon of Salmonella typhimurium. Microbiology 141(Part 7):1715-1722.
63. Zhang, X., S. M. Kelly, W. Bollen, and R. Curtiss III. 1999. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains. Microb. Pathog. 26:121-130.
64. Zhang, X., S. M. Kelly, W. S. Bollen, and R. Curtiss III. 1997. Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants. Infect. Immun. 65:5381-5387.